Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...

Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant ...

With iPSCs, you can pick the cells from one donor, reprogram them, identify the best clone and then you have access to a stable iPSC line that you can use forever. Therefore, providing an endless ...

Two clonal lines are available for cell therapy developers and pharmaceutical companies as off-the-shelf products in both GMP and research-grade. (PRNewsfoto/I Peace, Inc.) I Peace's new iPSC line ...

About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a ...

Two clonal lines are available for cell therapy developers and pharmaceutical companies as off-the-shelf products in both GMP and research-grade. I Peace's new iPSC line was generated from a ...

and iPSC-derived cell therapies, announced that the company has successfully generated iPS cell lines that are homozygous for HLA A, C, and DPA1. Two clonal lines are available for cell therapy ...

adding skin and human retinal iPSC-derived cell lines to its existing neuroscience, pain and touch, and cardiovascular products and services. Phenocell's offering includes market-leading human ...